Ophthalmic Drugs Market
According to Intent Market Research, the Ophthalmic Drugs Market is expected to grow from USD 35.3 billion in 2024-e at a CAGR of 6.1% to touch USD 50.4 billion by 2030. The Ophthalmic Drugs Market is dominated by key players such as, Novartis AG, Allergan (AbbVie), Santen Pharmaceutical Co. Ltd., Akorn Inc., and Johnson & Johnson Vision.